| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910984529103321 |
|
|
Autore |
Debela Bacha Kebede |
|
|
Titolo |
Public Administration in Ethiopia |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Leuven University Press, 2020 |
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
2. |
Record Nr. |
UNINA9911004827603321 |
|
|
Autore |
Burdick Donald L |
|
|
Titolo |
Petrochemicals in nontechnical language [[electronic resource] /] / Donald L. Burdick, William L. Leffler |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Tulsa, OK, : PennWell Corp., c2010 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[4th ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (402 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Petroleum chemicals |
Petroleum products |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
|
|
|
|
|
Nota di contenuto |
|
""CONTENTS""; ""FOREWORD""; ""PREFACE""; ""WHAT YOU NEED TO KNOW ABOUT CHEMISTRY""; ""PROCESSES AND EQUIPMENT""; ""BENZENE""; ""TOLUENE AND THE XYLENES""; ""OLEFIN PLANTS, ETHYLENE, AND PROPYLENE ""; ""CYCLOHEXANE""; ""THE C4 HYDROCARBONS FAMILY""; ""CUMENE AND PHENOL""; ""ETHYLBENZENE AND STYRENE""; ""ETHYLENE DICHLORIDE, VINYL CHLORIDE, AND EPICHLOROHYDRIN""; ""ETHYLENE OXIDE AND ETHYLENE GLYCOL""; ""PROPYLENE OXIDE AND PROPYLENE GLYCOL""; ""ETHANOLAMINES AND POLYOLS""; ""METHANOL AND SYNTHESIS GAS ""; ""FISCHER-TROPSCH PROCESS""; ""LOTS OF OTHER ALCOHOLS""; ""METHYL TERTIARY BUTYL ETHER "" |
|
|
|
|
|
|
|
|
|
|
|
|
|
""FORMALDEHYDE AND ACETALDEHYDE""""THE KETONES: ACETONE, METHYL ETHYL KETONE, AND METHYL ISOBUTYL KETONE""; ""THE ACIDS""; ""MALEIC ANHYDRIDE""; ""ACRYLONITRILE, ACRYLIC ACID, AND THE ACRYLATES""; ""ANILINE AND PHOSGENE""; ""BISPHENOL A""; ""ALPHA OLEFINS""; ""MAKING POLYMERS""; ""THERMOPLASTICS""; ""MDI AND TDI""; ""POLYURETHANE""; ""EPOXY RESINS AND POLYCARBONATES ""; ""FIBERS AND OTHER RESINS""; ""APPENDIX: CONVERSION AND YIELD CALCULATIONS""; ""GLOSSARY""; ""INDEX"" |
|
|
|
|
|
|
3. |
Record Nr. |
UNINA9910974461903321 |
|
|
Titolo |
Generating evidence for genomic diagnostic test development : workshop Summary / / Theresa Wizemann and Adam C. Berger, rapporteurs ; Roundtable on translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, D.C., : National Academies Press, 2011 |
|
|
|
|
|
|
|
ISBN |
|
0-309-21107-7 |
1-283-21343-5 |
9786613213433 |
0-309-21105-0 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (100 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
WizemannTheresa M |
BergerAdam C |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Genomics |
Diagnosis |
Gene mapping |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Contents""; ""Tables, Figures, and Boxes""; ""Abbreviations and Acronyms""; ""1 Introduction""; ""2 Stakeholder Perspectives on Evidence""; ""3 Approaches to Evidence Generation""; ""4 Overcoming Barriers for Evidence Generation""; ""5 Considerations Moving Forward""; ""6 Final |
|
|
|
|
|
|
|
|
|
|
|
Remarks""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Speaker Biographical Sketches""; ""Appendix C: Registered Attendees"" |
|
|
|
|
|
|
Sommario/riassunto |
|
"Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person's response to certain drugs, estimate the risk of developing Alzheimer's disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients' health.The Institute of Medicine (IOM) held a workshop to explore how researchers can gather better evidence more efficiently on the clinical utility of genetic tests. Generating Evidence for Genomic Diagnostic Test Development compares the evidence that is required for decisions regarding clearance, use, and reimbursement, to the evidence that is currently generated. The report also addresses innovative and efficient ways to generate high-quality evidence, as well as barriers to generating this evidence. Generating Evidence for Genomic Diagnostic Test Development contains information that will be of great value to regulators and policymakers, payers, health-care providers, researchers, funders, and evidence-based review groups."--Publisher's description. |
|
|
|
|
|
|
|
| |